| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 72.236 | 77.561 | 105.090 | 133.213 | 186.768 | 207.544 | 208.358 | 243.623 | 332.219 | 348.564 |
| Total Income - EUR | 73.541 | 77.561 | 105.090 | 133.213 | 186.768 | 207.720 | 208.358 | 243.623 | 332.219 | 348.606 |
| Total Expenses - EUR | 52.297 | 55.058 | 78.815 | 100.303 | 130.028 | 144.436 | 150.136 | 176.943 | 247.466 | 261.592 |
| Gross Profit/Loss - EUR | 21.244 | 22.504 | 26.275 | 32.910 | 56.740 | 63.284 | 58.222 | 66.680 | 84.753 | 87.014 |
| Net Profit/Loss - EUR | 17.845 | 20.952 | 25.224 | 31.578 | 54.873 | 61.208 | 56.138 | 64.244 | 81.431 | 76.889 |
| Employees | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Farmacia Belosanvet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 27.374 | 32.159 | 26.012 | 19.464 |
| Current Assets | 22.540 | 33.042 | 54.552 | 37.236 | 57.026 | 90.701 | 56.822 | 52.704 | 55.980 | 77.560 |
| Inventories | 10.199 | 8.163 | 11.795 | 12.736 | 14.329 | 15.532 | 19.400 | 30.408 | 37.834 | 45.407 |
| Receivables | 1.094 | 1.051 | 4.043 | 9.502 | 10.920 | 10.841 | 14.024 | 14.067 | 12.087 | 12.311 |
| Cash | 11.247 | 23.827 | 38.714 | 14.997 | 31.777 | 64.328 | 23.399 | 8.229 | 6.059 | 19.842 |
| Shareholders Funds | 18.611 | 30.467 | 50.337 | 33.285 | 53.437 | 80.989 | 73.612 | 70.998 | 76.448 | 90.416 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.928 | 2.575 | 4.216 | 3.951 | 3.589 | 9.711 | 10.584 | 13.865 | 5.544 | 6.608 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Belosanvet S.r.l.